Guardant Health, Inc. (GH) Q2 FY26 Earnings Call

Broad-based volume growth and Shield coverage wins drove higher guidance, while profitability remains investment-dependent.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Length63 minutes
EPS$-0.89
EPS consensus$-0.74

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26

All GH earnings ยท Back to GH overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.